Cervical cancer in a woman associated with long-term efalizumab therapy.
Morse
Lisa Guidry
LG
Yarbrough
Lee
L
Hogan
Daniel J
DJ
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006801:Humans; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab